New Ho r i z ons on Pharmaco t h e r apy i n Rheumatol o g y

Czech version

Authors: K. Šírová
Authors‘ workplace: Revmatická poradna Ostrava
Published in: Listy rev. Lék., , 2003, č. 2, s. 0
Category:

Overview

Majority of inflammatory rheumatoid diseases are of a multifactorial origin. Current development in geneticengineering and immunoendocrinology in relation to research in pharmacotherapy are directed to the core ofproblems related to chronic inflammatory and auto-immune diseases. The objective of this effort is to recognizethemost determining factors of pathogenesis.This trend is consequently reflected inpharmocotherapeutic effortsto influence the pathway of inflammation or patological procedure in immunity. Research in all disciplines is veryexpensive which is reflected in the price of pharmaceuticals. It is important that physicians are best acquaintedwith modern therapeutic possibilities and mechanisms of drugs in order to decide correctly on their indicationand benefit for the patient and to know risks related to medication in immunosuppression.

Key words:
multifactorial origin of rheumatoid diseases – division of rheumatoid diseases – immune andendocrine systems in relation to rheumatoid diseases – pharmacotherapy of rheumatoid diseases

Full text is not available online.

If interested in a scan of this journal, contact NTO ČLS JEP.

Labels

Medical assessment Occupational medicine

Rev i s o r y A c t i v i t y i n the Fi e l d o f Cl i n i c a l Psy c h o l o g y

Problems Ass o c i a t ed w i t h the Rev i s o r y Ac t i v i t y in Op h t a lmology

Pr a c t ic a l Commen t s on Rev i s o r y of La b o r a t o r i e s and C l i n i c a l B i o c h e m i s t r y

Article was published in

Revision Medicine Journal

2003 Issue 2